Thus, we conducted a comprehensive assessment and characterization of all new molecular entities, therapeutic biologics, and gene and cell therapies accredited through the FDA given that 1980. Moreover, we analyzed the acceptance pathways and regulatory designations inside the context of the legislative and regulatory landscape in the US. A https://gautamab051rjy6.luwebs.com/profile